Depression – Combatting Lack of Understanding
May is Mental Health Month and Dr. Michael Jablonski, Ph.D., M.S., Vice President of Medical Affairs for the GeneSight test at Myriad Genetics, discusses the results of a new GeneSight Mental Health Monitor national poll that found that 83 percent of those diagnosed with depression say life would be easier if others could understand what they’re going through. He shares other findings from the poll and talks about treatment options.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Mental health. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Mental health and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Mental health?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Michael Jablonski, Ph.D., M.S., Vice President of Medical Affairs for the GeneSight test at Myriad Genetics, discusses the results of a new GeneSight Mental Health Monitor natio…
- Key Point: He shares other findings from the poll and talks about treatment options.
- Key Point: Michael Jablonski, Ph.D., M.S, is the vice president of medical affairs for the GeneSight test at Myriad Genetics.
- Key Point: Jabolnski leads clinician education for Myriad Neuroscience by providing strategic direction for the field medical and medical information teams.
- Key Point: Jabolnski has an extensive background in neuroscience, genetics, personalized medicine, biotechnology, and academic research with multiple publications in the fields of psychiat…
Michael Jablonski, Ph.D., M.S, is the vice president of medical affairs for the GeneSight test at Myriad Genetics. Dr. Jabolnski leads clinician education for Myriad Neuroscience by providing strategic direction for the field medical and medical information teams. Dr. Jabolnski has an extensive background in neuroscience, genetics, personalized medicine, biotechnology, and academic research with multiple publications in the fields of psychiatry, pharmacogenomics, ALS, Parkinson’s disease, and sleep medicine. He holds multiple patents for novel treatments of neurodegenerative diseases. Dr. Jabolnski earned a Ph.D. in neuroscience from Thomas Jefferson University, a M.S. in medical sciences from Drexel University, and a B.A. in psychology from Northwestern University.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


